300 IR

DRUG3 trials

Sponsors

Stallergenes Greer

Conditions

Allergic Rhinitis Due to Grass PollensHouse Dust Mite AllergyPrimary DiseaseRhinitis, Allergic, Perennial

Phase 3

Safety and Efficacy on Phase III Study on 300 IR SLIT to Patients Suffering From Grass Pollen Rhinoconjunctivitis

CompletedNCT00803244

Stallergenes GreerPrimary Disease

Start: 2009-01-31End: 2010-01-31Updated: 2016-05-25

Study of Efficacy and Safety of 300 IR Sublingual Immunotherapy (SLIT) Tablets in Adult Patients With Allergic Grass Pollen Rhinoconjunctivitis

CompletedNCT00955825

Stallergenes GreerAllergic Rhinitis Due to Grass Pollens

Start: 2008-10-31End: 2009-08-31Updated: 2016-05-19

Efficacy & Safety of STG320 Sublingual Tablets of HDM Allergen Extracts in Adults and Adolescents With HDM-associated AR

CompletedNCT02443805

Stallergenes GreerHouse Dust Mite Allergy, Rhinitis, Allergic, Perennial

Start: 2015-09-29End: 2018-06-25Updated: 2019-10-14

Related Papers

Safety of 300IR house dust mite sublingual tablet from pooled clinical trial and post-marketing data.

2024-06-251 citations

Clinical benefits with 300 IR HDM SLIT tablet in Europeans with house dust mite allergic rhinitis: Post hoc analysis of a large phase 3 trial.

2023-12-221 citations

Comparison of scores associating symptoms and rescue medication use for evaluating the efficacy of allergy immunotherapy in seasonal allergic rhinoconjunctivitis: results from five trials.

2016-12-025 citations